NuCana (NCNA)
(Delayed Data from NSDQ)
$0.03 USD
0.00 (-1.83%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.03 0.00 (-6.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NCNA 0.03 0.00(-1.83%)
Will NCNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NCNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NCNA
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks
NCNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study
Other News for NCNA
NuCana PLC (ADR) trading halted, news pending
12 Health Care Stocks Moving In Thursday's After-Market Session
NuCana (NCNA) Modifies ADS to Ordinary Shares Ratio
NuCana Announces ADS Ratio Change | NCNA Stock News
NuCana announces ADS ratio change